Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-01-11 00:00:00 ET · period of report 2024-01-09 · accession 0001209191-24-001486 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-01-11 | 2024-01-09 | RXRX | Li Dean Y | Dir | S - Sale | $13.66 | -29.0K | 422.0K | -6% | -$396.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-01-09 | S | D | 962 | $14.03 | 421,000 | I By Dean Y. Li 2021 Family Trust | — | — | (F4) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $14 to $14.08 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. (F3) The shares are held by the Dean Y. Li 2021 Family Trust, of which the Reporting Person's spouse serves as trustee. |
| 2 | Common | Class A Common Stock | 2024-01-09 | S | D | 28,038 | $13.65 | 421,962 | I By Dean Y. Li 2021 Family Trust | — | — | (F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13 to $13.99 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. (F3) The shares are held by the Dean Y. Li 2021 Family Trust, of which the Reporting Person's spouse serves as trustee. |